Pill Identifier App

Hydroxycarbamide

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX05

CAS registry number (Chemical Abstracts Service)

0000127-07-1

Chemical Formula

C-H4-N2-O2

Molecular Weight

76

Therapeutic Category

Cytostatic agent

Chemical Names

Carbamohydroxamic acid

Carbamohydroximic acid

Carbamoyl oxime

Carbamyl hydroxamate

Hydroxylamine, N-(aminocarbonyl)-

Hydroxylamine, N-carbamoyl-

Hydroxyurea (WHO)

N-Carbamoylhydroxylamine

N-Hydroxyharnstoff (IUPAC)

N-Hydroxymocovina

Urea, hydroxy- (USAN)

Foreign Names

  • Hydroxycarbamidum (Latin)
  • Hydroxycarbamid (German)
  • Hydroxycarbamide (French)
  • Hidroxicarbamida (Spanish)

Generic Names

  • Hydroxycarbamide (OS: DCF, BAN)
  • Hydroxyurea (OS: USAN)
  • Idroxicarbamide (OS: DCIT)
  • 4-03-00-00170 (IS: Beilstein)
  • AI3-51139 (IS)
  • BRN 1741548 (IS)
  • CCRIS 958 (IS)
  • EINECS 204-821-7 (IS)
  • HSDB 6887 (IS)
  • NCI-C04831 (IS)
  • NSC 32065 (IS)
  • SK 22591 (IS)
  • SQ 1089 (IS)
  • Hydroxycarbamid (PH: Ph. Eur. 7)
  • Hydroxycarbamide (PH: BP 2011, Ph. Eur. 7)
  • Hydroxycarbamidum (PH: Ph. Eur. 7)
  • Hydroxyurea (PH: USP 34)

Brand Names

  • Apo-Hydroxyurea
    Apotex, Canada; Apotex, Hong Kong
  • Droxamida
    AC Farma, Peru
  • Droxia
    Bristol-Myers Squibb, United States
  • Hidroksikarbamid
    Habit, Serbia
  • Hidroxcarbamida Kampar
    Kampar, Chile
  • Hidroxiurea Asofarma
    Raffo, Argentina
  • Hidroxiurea Delta Farma
    Delta Farma, Argentina
  • Hidroxiurea Dosa
    Dosa, Argentina
  • Hidroxiurea Filaxis
    Filaxis, Argentina
  • Hidroxiurea Lafedar
    Lafedar, Argentina
  • Hidroxiurea Martian
    LKM, Argentina
  • Hidroxiurea Microsules
    Microsules, Argentina
  • Hidroxiurea Rontag
    Rontag, Argentina
  • Hidroxiurea
    Pharmaceutical, Venezuela
  • Hondrea
    Alkem, India
  • Hydab
    Fresenius, Philippines
  • Hydrea
    Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, United Arab Emirates; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Egypt; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Georgia; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iraq; Bristol-Myers Squibb, Iran; Bristol-Myers Squibb, Jordan; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Kuwait; Bristol-Myers Squibb, Lebanon; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Qatar; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Saudi Arabia; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Syria; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Turkey; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Yemen; Bristol-Myers Squibb, South Africa; Corden Pharma, Estonia; Medicines Group, New Zealand; Orifarm, Norway; P & D, Malta
  • Hydréa
    Bristol-Myers Squibb, France
  • Hydreasyn
    FarmaSyn, Greece
  • Hydrine
    Meizler, Brazil
  • Hydrox
    Cipla, Philippines
  • Hydroxycarbamid HEXAL
    Hexal, Germany
  • Hydroxycarbamid Pliva
    Pliva, Poland
  • Hydroxycarbamide medac
    medac, United Kingdom
  • Hydroxycarbamide
    Pliva, Lithuania
  • Hydroxycarbamide-Jialin Pharm
    Jialin, China
  • Hydroxyurea Medac
    Medac, Denmark; Medac, Sweden
  • Hydroxyurea medac
    medac, Austria
  • Hydroxyurea
    Par, United States; Pliva Pliva Hrvatska, Russian Federation; Roxane, United States; Teva, United States
  • Hytinon
    Korea United Pharm, Vietnam
  • Krabinex
    Korea United Pharma, Philippines
  • Leukocel
    Celon, India
  • Litalir
    Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Bosnia & Herzegowina; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Slovakia; PharmaSwiss, Croatia (Hrvatska)
  • Onco-Carbide
    Teofarma, Italy
  • Oxyrea
    Cadila, India
  • Rexinth
    Richmond, Argentina
  • Siklos
    Addmedica, France; Addmedica, Greece; Addmedica, Lithuania; Addmedica, Luxembourg; Nordic Pharma, Germany; Nordic Pharma, United Kingdom; Nordic Pharma, Netherlands; Rovi, Spain
  • Syrea
    medac, Germany
  • Urdox
    Zydus, India

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web4)